Perspective Therapeutics Inc. is a medical technology and radiopharmaceutical company which provide advanced treatment applications for cancers. The Company is the sole producer of Cesium-131 brachytherapy seeds. Perspective Therapeutics Inc., formerly known as Isoray Inc., is based in RICHLAND, Wash.
| Revenue (Most Recent Fiscal Year) | $0.88M |
| Net Income (Most Recent Fiscal Year) | $-103.12M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 541.71 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.51 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -11813.12% |
| Net Margin (Trailing 12 Months) | -11665.27% |
| Return on Equity (Trailing 12 Months) | -41.79% |
| Return on Assets (Trailing 12 Months) | -34.76% |
| Current Ratio (Most Recent Fiscal Quarter) | 5.17 |
| Quick Ratio (Most Recent Fiscal Quarter) | 5.17 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.01 |
| Inventory Turnover (Trailing 12 Months) | -- |
| Book Value per Share (Most Recent Fiscal Quarter) | $2.79 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | $-1.41 |
| Diluted Earnings per Share (Trailing 12 Months) | -- |
| Exchange | NYSEMKT |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 114.02M |
| Free Float | 110.00M |
| Market Capitalization | $478.88M |
| Average Volume (Last 20 Days) | 0.96M |
| Beta (Past 60 Months) | 1.86 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 3.52% |
| Percentage Held By Institutions (Latest 13F Reports) | 54.66% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |